Corresponding Author: Josef Coresh, MD, PhD, Johns Hopkins Bloomberg School of Public Health, 2024 E Monument St, Ste 2-630, Baltimore, MD 21287 (email@example.com).
Published Online: August 8, 2022. doi:10.1001/jama.2022.12407
Correction: This article was corrected on December 13, 2022, to correct an error in the SI conversion for creatinine to µmol/L in Table 1.
Conflict of Interest Disclosures: Dr Shlipak reported receiving grants from the National Institutes of Health/National Heart, Lung, and Blood Institute/National Institute on Aging/National Institute of Diabetes and Digestive and Kidney Diseases during the conduct of the study and grants from Bayer Pharmaceuticals and personal fees from Cricket Health, Intercept Pharmaceuticals, Bayer Pharmaceuticals, AstraZeneca, and Boehringer Ingelheim outside the submitted work. Dr Inker reported receiving grants from the National Institutes of Health and providing consultancy to Health Logics outside the submitted work. Dr Coresh reported consulting for Health.io during the conduct of the study and consulting for SomaLogic and receiving grants from the National Institutes of Health and National Kidney Foundation outside the submitted work.
LA , Eneanya
ND , Coresh
et al; Chronic Kidney Disease Epidemiology Collaboration. New creatinine- and cystatin C-based equations to estimate GFR without race. N Engl J Med
. 2021;385(19):1737-1749. doi:10.1056/NEJMoa2102953PubMedGoogle ScholarCrossref
C , Baweja
M , Crews
et al. A unifying approach for GFR estimation: recommendations of the NKF-ASN Task Force on reassessing the inclusion of race in diagnosing kidney disease. Am J Kidney Dis
. 2022;79(2):268-288.e1. doi:10.1053/j.ajkd.2021.08.003PubMedGoogle ScholarCrossref
OM , Sang
Y , Grams
et al; Chronic Kidney Disease Prognosis Consortium. Association of estimated GFR calculated using race-free equations with kidney failure and mortality by black vs non-black race. JAMA
. 2022;327(23):2306-2316. doi:10.1001/jama.2022.8801PubMedGoogle ScholarCrossref